Last updated on April 18, 2014 at 17:24 EDT

Marketsandmarkets: Global PET and SPECT Market is Expected to Reach $1,466 Million by 2016

October 26, 2011

DALLAS, October 26, 2011 /PRNewswire/ –

The report “PET (Positron Emission Tomography) and SPECT (Single Photon
Emission Computed Tomography) Global Market (Technology and Applications)
(2011-2016) [
http://www.marketsandmarkets.com/Market-Reports/pet-market-98.html ]”
analyzes and studies the major market drivers, restraints, and opportunities
in North America, Europe, Asia, Japan, and Rest of the World.

Browse market data tables and in-depth TOC on PET (Positron Emission
Tomography) and SPECT (Single Photon Emission Computed Tomography) Global
Market (Technology and Applications) (2011-2016).
http://www.marketsandmarkets.com/Market-Reports/pet-market-98.html Early
buyers will receive 10% customization on reports.

This report studies the global PET and SPECT market [
http://www.marketsandmarkets.com/Market-Reports/pet-market-98.html ]
divided into standalone (PET and SPECT) and hybrid variants (PET/CT and
SPECT/CT) over the forecasted period (2011-2016).

PET holds the largest share (53.6%) of the PET-SPECT market, dominated
by PET/CT holding the share of 95% in the PET modality. Standalone PET is
declining continuously and the market will be taken over by PET/CT by 2017.
SPECT/CT is driving the SPECT market.

Reimbursement will be a major factor to determine the future of the
nuclear imaging industry. There would be delays in reimbursement procedures
if the economic recession is observed. Besides, reimbursement will determine
the respective technology used for the concerned application.

Developed nations are driving the SPECT/CT market, SPECT/CT being a new
technology with low market penetration. The PET/CT market is driven by APAC
(excluding Japan) and Rest of the World, where the companies can expand
their presence, growing at a higher single digit growth rate. Developing
nations have to be robust in terms of infrastructure to support the growth
of PET technology.

Majority of end users of nuclear medicine are hospitals as adequate
capital leverage and sufficient space are more readily available there. The
share of hospitals has been increasing year after year; in the year 2003 it
was 70% while in 2010 it became 95%.

Other Reports by MarketsandMarkets

        - Diagnostic Imaging Market @


        - Healthcare IT Market @


        - US Biopharmaceutical Industry @


        - Stem Cell Technologies Market @


        - Respiratory Care Devices Market @


        - Microscopy Market in Latin America @


Upcoming Market Research by MarketsandMarkets

        - Magnetic Resonance Imaging Market @


        - Ultrasound Market @


        - Diabetes Care Devices Market @


About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company
based in the U.S. We publish strategically analyzed market research reports
and serve as a business intelligence partner to Fortune 500 companies across
the world.

MarketsandMarkets also provides multi-client reports, company profiles,
databases, and custom research services. MarketsandMarkets covers thirteen
industry verticals; including advanced materials, automotives and
transportation, banking and financial services, biotechnology, chemicals,
consumer goods, energy and power, food and beverages, industrial automation,
medical devices [


], pharmaceuticals, semiconductor and electronics, and telecommunications
and IT.

We at MarketsandMarkets are inspired to help our clients grow by
providing apt business insight with our huge market intelligence repository.
To know more about us and our reports, please visit our website


        Mr. Rohan
        7557 Rambler Road,
        Suite 727, Dallas, TX 75231
        Tel: +1-888-6006-441
        Email:  sales@marketsandmarkets.com
        MarketsandMarkets Blog @  http://www.marketsandmarketsblog.com


SOURCE MarketsandMarkets

Source: PR Newswire